Mei Pharma Inc (MEIP)

$7.34 0.26 (3.67%)

15:39 EDT MEIP Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 6, 2022

Good morning, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

More Articles

Volume:

Previous Close -

Market Cap 48.91M

PE Ratio 1.56

EPS 4.72

Volume (Avg. Vol.) 24,760

Day's Range $7.02 - $7.36

52-Week Range $4.00 - $13.60

Dividend & Yield N/A (N/A)

MEIP Stock Predictions, Articles, and Mei Pharma Inc News

From InvestorPlace
From the Web

Penny Stocks Today: Why MEIP and HNST Are Plunging Friday

By William White, InvestorPlace Writer Mar 25, 2022

We're checking in on the latest penny stocks news for today with two companies that investors are watching fall on Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Mar 25, 2022

Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday!

37 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 26, 2016

This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

52 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

27 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 7, 2016

This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

13 Biotechnology Stocks to Buy Now

By Portfolio Grader Aug 22, 2016

The grades of 13 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

Hottest Manufacturing Stocks Now – MEIP PRAN LPTH ONVO

By Portfolio Grader Aug 8, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

41 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 25, 2016

The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

MEI Pharma and Infinity Pharma ink all-stock merger deal (NASDAQ:MEIP)

From Seeking Alpha Feb 23, 2023

Oncology-focused biotechs MEI Pharma (MEIP) and Infinity Pharmaceuticals (INFI) announced a merger agreement Thursday to combine in an all-stock transaction. Read the full story here.

MEI Pharma slumps on ending lead drug development ex-Japan, analysts downgrade stock

From Seeking Alpha Dec 6, 2022

Shares of micro-cap biotech MEI Pharma (MEIP) slumped 34.3% to $0.26 in Tuesday morning trade, as analysts downgraded the stock after the company ended its lead drug development outside...

Brookline Capital Markets Remains a Buy on MEI Pharma (MEIP)

From TipRanks Dec 6, 2022

In a report released yesterday, Leah R. Cann from Brookline Capital Markets maintained a Buy rating on MEI Pharma (MEIP – Research Report), with a ...

MEI Pharma (MEIP) Receives a Buy from H.C. Wainwright

From TipRanks Nov 16, 2022

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on MEI Pharma (MEIP – Research Report), with a price target of $5.00. The...

MEI Pharma (MEIP) Gets a Buy from BTIG

From TipRanks Nov 16, 2022

BTIG analyst Justin Zelin reiterated a Buy rating on MEI Pharma (MEIP – Research Report) yesterday and set a price target of $2.00. The company’s shares...

MEI Pharma (MEIP) Gets a Buy from Brookline Capital Markets

From TipRanks Nov 15, 2022

In a report released yesterday, Leah R. Cann from Brookline Capital Markets maintained a Buy rating on MEI Pharma (MEIP – Research Report), with a price targe...